Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/11/21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/06/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/03/18 |
Mats Blom
BRD | Director/Board Member | 59 | 01/04/17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Coordinate società
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+11,91% | 114 Mrd | |
+11,60% | 105 Mrd | |
-4,68% | 23,83 Mrd | |
-0,82% | 21,73 Mrd | |
-10,12% | 18,1 Mrd | |
-42,12% | 16,34 Mrd | |
-17,47% | 16,13 Mrd | |
+2,77% | 13,75 Mrd | |
+34,58% | 11,76 Mrd |